drugset / Trial / NCT00236912

A Study Comparing Safety and Efficacy of Levofloxacin and Metronidazole Versus Piperacillin/Tazobactam in Treating Complicated Appendicitis

NCT00236912 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy and safety of two treatment regimens in treating patients with complicated appendicitis. Appendicitis requires antibiotic treatment when the appendix ruptures (complicated appendicitis). This is a study comparing intravenous (IV) antibiotic therapy of levofloxacin/metronidazole versus piperacillin/tazobactam for 4 to 14 days. Patients may be switched to oral therapy after 48 hours, at the doctor's discretion.

Timeline

Start
2003-07
Primary completion
—
Completion
2004-09

Outcome

Outcome not reported

Stopped (Enrollment): “This study was terminated due to low enrollment.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 750 mg Intravenous
Subject Metronidazole Small molecule 1500 mg Intravenous

Indications